Pascal Ghoson, CEO of Oxurion, said: “Oxurion today presents its new strategy, which aims to further diversify current activities and reduce risks. We will continue our activities with 10 employees from March 2024 and will seek M&A (acquisition) opportunities, with a focus on healthcare companies to leverage the team’s expertise. This approach is not just about growth; it’s about strengthening our presence on the market with the help of a solid business plan.”
Improvement of the financing strategy
Atlas is currently Oxurion’s main financial partner, having invested in the company through convertible bonds. “Going forward, we intend to use equity and bond financing to achieve our M&A objectives. We are considering M&A transactions in the healthcare space, where we can add the most value with the current team. Our M&A activities will therefore mainly focus on healthcare in France and the Benelux. We are interested in mature, revenue-generating companies with low risk and high potential,” adds Pascal Ghoson.
Find the full press release below: